Ticker

Analyst Price Targets — BLUE

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 22, 2022 2:49 pmGena WangBarclays$5.00$5.83Pulse 2.0 Bluebird Bio (BLUE) Stock: $5 Target And Equal-Weight Rating
March 7, 2022 12:00 amDavid NierengartenWedbush$6.48$2.88Pulse 2.0 bluebird bio (BLUE) Stock: $10 Price Target And Neutral Rating
November 19, 2021 12:00 amCory KasimovJ.P. Morgan$14.00$10.70StreetInsider bluebird bio (BLUE) PT Lowered to $14 at JPMorgan
November 12, 2021 12:00 amZhiqiang ShuBerenberg Bank$11.00$11.68StreetInsider bluebird bio (BLUE) PT Lowered to $11 at Berenberg
November 8, 2021 12:00 amSalveen RichterGoldman Sachs$10.00$10.70TheFly Bluebird Bio (BLUE) downgraded to Sell from Neutral at Goldman Sachs
September 13, 2021 12:00 amJoshua SchimmerEvercore ISI$25.00$11.84Investing Evercore ISI Stick to Their Buy Rating for bluebird bio
August 10, 2021 12:00 amJohn NewmanCanaccord Genuity$20.00$12.97TheFly Bluebird Bio downgraded to Hold from Buy at Canaccord
August 9, 2021 12:00 amBenjamin BurnettStifel Nicolaus$18.00$11.76TheFly Bluebird Bio price target lowered to $18 from $31 at Stifel

Latest News for BLUE

FULTON FINANCIAL MERGES ITS BLUE FOUNDRY BANK SUBSIDIARY INTO FULTON BANK, N.A.

Former Blue Foundry Bank customers now have access to full suite of   Fulton Bank products, services and financial centers LANCASTER, Pa., July 13, 2026 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ: FULT) ("Fulton") announced the merger of Blue Foundry Bank with and into Fulton Bank, N.A.

PRNewsWire • Jul 13, 2026
Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting

Election of Even a Single DOMA Nominee Would Risk Compromising Pacira's Strong Forward Momentum Leading Independent Experts ISS, Glass Lewis and Egan-Jones Agree that DOMA Representation Is Not Warranted BRISBANE, Calif., June 4, 2026 /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform…

PRNewsWire • Jun 4, 2026
ISS and Glass Lewis Support BIMIZCI's Case for Change at Medallion Financial. Both Recommend Stockholders Vote on the BLUE Proxy Card FOR Election of Two BIMIZCI Nominees to Medallion Board

MINNEAPOLIS--(BUSINESS WIRE)---- $MFIN #ActivistInvesting--BIMIZCI Fund LLC, Warnke Investments LLC, ZimCal Asset Management, LLC and Stephen Hodges (collectively, "BIMIZCI" or "we"), long-standing holders of Medallion Financial Corp. (NASDAQ: MFIN) ("Medallion" or the "Company") trust preferred securities and currently the 4th largest institutional stockholder with 500,250 shares, announced today that both leading…

Business Wire • May 29, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for BLUE.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top